Crystallographic studies of the Anthrax lethal toxin. Annual report
The lethal form of Anthrax results from the inhalation of anthrax spores. Death is primarily due to the effects of the lethal toxin (Protective Antigen (PA) + Lethal Factor) from the causative agent, Bacillus anthracis. All the Anthrax vaccines currently in use or under development contain or produce PA, the major antigenic component of anthrax toxin, and there is a clear need for an improved vaccine for human use. In the previous report we described the first atomic resolution structure of PA, revealing that the molecule is composed largely of beta-sheets organized into four domains. This information can be used in the design. of recombinant PA vaccines. In this report we describe additional features of the full-length PA molecule derived from further crystallographic refinement and careful examination of the structure. We compare two crystal forms of PA grown at different pH values and discuss the functional implications. A complete definition of the function of each domain must await the crystal structure of the PA63 heptamer. We have grown crystals of the heptamer under both detergent and detergent-free conditions, and made substantial progress towards the crystal structure. The mechanism of anthrax intoxication in the light of our results is reviewed.
- Research Organization:
- Dana-Farber Cancer Inst., Boston, MA (United States)
- OSTI ID:
- 415913
- Report Number(s):
- AD-A--314005/0/XAB; CNN: Contract DAMD17-94-C-4047
- Country of Publication:
- United States
- Language:
- English
Similar Records
Cryo-electron microscopy study of bacteriophage T4 displaying anthrax toxin proteins
Rabies virus glycoprotein as a carrier for anthrax protective antigen